Skip to main content

Month: August 2021

Integrity Applications, Inc. Implements Reverse Stock Split To Meet NASDAQ Initial Listing Requirements

Wilmington, DE and Ashdod, Israel, Aug. 12, 2021 (GLOBE NEWSWIRE) — Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, announced today that it has implemented a 1-for-13 reverse split of its issued and outstanding shares of common stock, to be effective prior to the opening of the market on Friday, August 13, 2021. The reverse stock split was previously approved by the Company’s stockholders at the Annual Meeting of Stockholders held on March 24, 2020. On July 28, 2021, the Company’s Board of Directors approved the implementation of the reverse stock split and determined the appropriate reverse stock split to be a ratio of 1-for-13. The reverse stock split is being implemented by the...

Continue reading

CareCloud breaks new ground with integration of consulting and on-demand revenue cycle management staffing services

SOMERSET, N.J., Aug. 12, 2021 (GLOBE NEWSWIRE) — CareCloud, Inc. (Nasdaq: MTBC) (Nasdaq: MTBCP), a leader in cloud-based healthcare technology and revenue cycle solutions, is proud to announce that its newly formed medSR division is already proving to be an integral partner to medical groups needing the right mix of people, processes and technology to optimize performance. medSR is a subsidiary of CareCloud that offers in-depth knowledge and experience in planning and executing transformational projects, providing a full suite of consulting solutions that address clients’ biggest technology and staffing challenges across business intelligence, analytics, technology planning and transformation, interoperability, integration, regulatory compliance, and performance improvement. medSR recently marked a significant milestone in signing...

Continue reading

Tarsus Pharmaceuticals, Inc. Appoints Pharmaceutical and Healthcare Industry Leader Rosemary A. Crane to Board of Directors

Ms. Crane brings over 30 years of experience in executive leadership, commercialization, and business development in the pharmaceutical and healthcare industries IRVINE, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced the appointment of Rosemary A. Crane to its Board of Directors. Ms. Crane will serve as the Chair of the newly created Science and Technology Committee, focused on external and internal innovation and pipeline opportunities. Ms. Crane has more than 30 years of extensive experience in the pharmaceutical industry, including executive leadership, board service, innovation,...

Continue reading

GeoVax to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021

ATLANTA, GA, Aug. 12, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against infectious diseases and cancers, today announced that it will be presenting at the SNN Network Summer Virtual Event 2021 on Wednesday, August 18, 2021 at 12:30 PM EST. David Dodd, Chairman and CEO, will be hosting the presentation and answering questions from investors. To access the live presentation, please use the following information: SNN Network Summer Virtual Event 2021 Date: Wednesday/Thursday, August 18/19, 2021 Time: 12:30 PM Eastern Time (9:30 AM Pacific Time) Webcast: https://www.webcaster4.com/Webcast/Page/2750/42256 If you would like to book one-on-one investor meetings with GeoVax, and to watch the Company’s presentation, please make sure...

Continue reading

DIVERGENT Energy Services Announces the Release of Q2 2021 Financial Results

Symbol (DVG: TSX-V) CALGARY, Alberta, Aug. 12, 2021 (GLOBE NEWSWIRE) — DIVERGENT Energy Services Corp. (“Divergent”, the “Company“, or “DVG”) announces the release of its financial results for the three and six months ended June 30, 2021. All amounts are in thousands (000’s) of United States Dollars, unless otherwise noted. HIGHLIGHTS FOR THE QUARTERRevenues of $1,991, an increase of 427% over Q2 2020. Operating income of ($57) and adjusted EBITDA of ($13) in Q2 2021 as compared to ($316) and ($201) in Q2 2020 demonstrated improved operating performance year over year. Cash flow in the quarter was sufficient to pay interest on debentures in cash, and not in shares of the Company as done in previous quarters.INDUSTRY OUTLOOK The continuous increases in the oil and gas commodity prices are expected to increase submersible...

Continue reading

Verisk’s FAST Recognized as a Leader in 2021 Gartner® Magic Quadrant™ for Fourth Consecutive Year

FAST platform recognized for ability to execute and completeness of vision in North America Life Insurance Policy Administration Systems JERSEY CITY, N.J, Aug. 12, 2021 (GLOBE NEWSWIRE) — Verisk’s FAST platform for the insurance and annuity industry has been recognized for the fourth year in a row as a Leader in the Gartner Magic Quadrant report. Gartner recognized Verisk’s FAST, in the August 2021 edition* as a Leader for Individual and Group Life Insurance Policy Administration Systems in North America. Gartner has recognized FAST in this Magic Quadrant report for the past six years. FAST, which stands for “Flexible Architecture, Simplified Technology,” provides a scalable technology platform that life insurers can use to help enhance or replace their legacy policy administration systems quickly. Since its acquisition by Verisk...

Continue reading

Sunshine Biopharma’s Coronavirus Treatment Anticipated to be Effective Against Delta and the Other Variants of Concern

MONTREAL, Aug. 12, 2021 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (OTC Pink: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs today announced that it mapped the mutations found in Delta and the other variants of concern (“VOC”) identified to date and determined that the majority of the mutations are in the Spike protein and only a few fall within the genomic sequences that encode nsp3, a multi-domain protein that includes the PLpro enzyme. Serendipitously, no mutations mapped within the domain comprising the PLpro catalytic core. These finding indicate that our PLpro inhibitors currently under development at the University of Georgia would likely be effective against all of the VOC. The VOC currently recognized by the World Health Organization and the CDC in...

Continue reading

REPEAT — Alkaline Fuel Cell Power Corp. Provides Technology and Target Market Overview

Technology derived from the European Space Agency Fuel cell energy source that generates zero CO2 emissions with pure water as the only by-product Ideally suited for residential and small- to medium-sized power markets Attractive production costs for boiler replacement across Europe with absence of noble metalsVANCOUVER, British Columbia, Aug. 12, 2021 (GLOBE NEWSWIRE) — Alkaline Fuel Cell Power Corp. (NEO: PWWR) (Frankfurt: 77R, WKN: A3CTYF) (“AFCP” or the “Company“), a company engaged in the development and production of alkaline fuel cell heat and power systems for residential, industrial and commercial markets, today provides an overview on our technology and our target markets. “Our hydrogen powered alkaline fuel cell technology is being positioned to offer all of Europe an energy source that generates...

Continue reading

RocketFuel Announces Revised Terms for an Equity Follow-On Investment of Up To $2.25 Million

SAN FRANCISCO, Aug. 12, 2021 (GLOBE NEWSWIRE) — RocketFuel (OTC: RKFL) (“RocketFuel” or the “Company”), a global provider of one-click online payment options using Bitcoin and 50+ other cryptocurrencies, today announced that it had reached a revised agreement with a private investor for an up to $2.25 million follow-on equity investment. The investor had previously invested $1.5 million by purchasing restricted shares of common stock under a warrant. As part of that transaction, RocketFuel had issued a second warrant to the investor covering 1,500,000 shares with a purchase price of $1.50 per share. The investor and RocketFuel have now agreed to increase the warrant to 2,250,000 restricted shares and to lower the exercise price to $1.00 per share. In addition, the investor has committed to purchase 100,000...

Continue reading

Global Helium Corp. Adds Second Core Area and Additional Acreage in Saskatchewan’s Helium Fairway

CALGARY, Alberta, Aug. 12, 2021 (GLOBE NEWSWIRE) — Global Helium Corp. (CSE: HECO) (the “Company” or “Global”), an established team of global helium industry experts, is pleased to announce it has established an initial position in a second core area in Saskatchewan. The new acreage, when combined with the Company’s current land position, increases Global’s land holdings to over 405,000 acres in southern Saskatchewan. The Company has established a core area at Vermillion Hills, approximately 150 kilometers northeast of Swift Current, of 135,015 ha (333,630 acres). The company has now established a second core area south of Regina where Global was recently awarded a new land permit consisting of 29,180 ha (72,105 acres). Combined, Global has increased its total land holdings in Saskatchewan to approximately 164,195 ha (405,725 acres). The...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.